# EDGAR Filing Document

**Accession Number:** 0001000694
**File Stem:** 0001104659-26-049137
**Filing Date:** 2026-4
**Character Count:** 1100
**Document Hash:** a00b41b1e124b0df4f26ecb75c32ef7e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-049137.hdr.sgml**: 20260427

**ACCESSION NUMBER**: 0001104659-26-049137

**CONFORMED SUBMISSION TYPE**: ARS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260427

**DATE AS OF CHANGE**: 20260427

**EFFECTIVENESS DATE**: 20260427

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NOVAVAX INC
- **CENTRAL INDEX KEY:** 0001000694
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 222816046
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** ARS
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26770
- **FILM NUMBER:** 26897297

**BUSINESS ADDRESS:**
- **STREET 1:** 21 FIRSTFIELD RD
- **CITY:** GAITHERSBURG
- **STATE:** MD
- **BUSINESS PHONE:** 240-268-2000

**MAIL ADDRESS:**
- **STREET 1:** 21 FIRSTFIELD RD
- **CITY:** GAITHERSBURG
- **STATE:** MD

### Attached PDF Documents

**Attachment 1:** `tm2612430d1_ars.pdf`

_No text found in this document._